168 related articles for article (PubMed ID: 6316838)
1. Hepatitis A virus immunoglobulin M antibody in acute neurological disease.
Bosch VV; Dowling PC; Cook SD
Ann Neurol; 1983 Dec; 14(6):685-7. PubMed ID: 6316838
[TBL] [Abstract][Full Text] [Related]
2. [Hepatitis A virus infection, an etiologic factor in chronic active diseases of the liver? IgM antibody of the hepatitis A virus].
Dávid K; Halmy L
Orv Hetil; 1986 Feb; 127(5):261-3. PubMed ID: 3005941
[No Abstract] [Full Text] [Related]
3. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barré syndrome associated with acute hepatitis A.
Igarashi M; Tomono M; Uchida S; Yamashiro Y; Namihisa T; Tanaka S
Gastroenterol Jpn; 1983 Dec; 18(6):549-52. PubMed ID: 6608463
[TBL] [Abstract][Full Text] [Related]
5. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
Shimoya K; Ohnishi A; Hashimoto T; Yuki N
Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
[TBL] [Abstract][Full Text] [Related]
6. Case report: Hepatitis A preceding Guillain-Barré syndrome.
Chitambar SD; Fadnis RS; Joshi MS; Habbu A; Bhatia SG
J Med Virol; 2006 Aug; 78(8):1011-4. PubMed ID: 16789022
[TBL] [Abstract][Full Text] [Related]
7. Mycoplasma antibody in Guillain-Barré syndrome and other neurological disorders.
Goldschmidt B; Menonna J; Fortunato J; Dowling P; Cook S
Ann Neurol; 1980 Feb; 7(2):108-12. PubMed ID: 7369715
[TBL] [Abstract][Full Text] [Related]
8. In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes.
Sawant-Mane S; Clark MB; Koski CL
Ann Neurol; 1991 Apr; 29(4):397-404. PubMed ID: 1718212
[TBL] [Abstract][Full Text] [Related]
9. [Guillain-Barré syndrome following acute hepatitis A].
Endoh J; Ogasawara N; Mushimoto M
Rinsho Shinkeigaku; 1991 Feb; 31(2):210-2. PubMed ID: 2060247
[TBL] [Abstract][Full Text] [Related]
10. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
Tang J; Yuan J; Hao H
Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
[TBL] [Abstract][Full Text] [Related]
11. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
[TBL] [Abstract][Full Text] [Related]
12. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
Hartung HP; Reiners K; Schmidt B; Stoll G; Toyka KV
Ann Neurol; 1991 Jul; 30(1):48-53. PubMed ID: 1929228
[TBL] [Abstract][Full Text] [Related]
13. The Guillain-Barré syndrome following dengue fever.
Esack A; Teelucksingh S; Singh N
West Indian Med J; 1999 Mar; 48(1):36-7. PubMed ID: 10375992
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
Gregson NA; Koblar S; Hughes RA
Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
[TBL] [Abstract][Full Text] [Related]
15. [Guillain-Barré syndrome with favorable outcome in a case of recent human immunodeficiency virus infection].
Persuy P; Arnott G; Fortier B; Ajana F; Blondel M; Fourrier F; Dewilde A; Maniez-Montreuil M
Rev Neurol (Paris); 1988; 144(1):32-5. PubMed ID: 2831607
[TBL] [Abstract][Full Text] [Related]
16. [Detection of IgM anti-hepatitis A antibodies by immunoenzyme technic. Interpretation of results and comparison of 2 tests (Havab-M EIA and Hepanostika anti-HAV IgM].
Barin F; Lesage G; Dubois F; Yvonnet B; Coursaget P; Goudeau A
Pathol Biol (Paris); 1983 Dec; 31(10):825-8. PubMed ID: 6322094
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome.
Sharief MK; McLean B; Thompson EJ
Ann Neurol; 1993 Jun; 33(6):591-6. PubMed ID: 8498839
[TBL] [Abstract][Full Text] [Related]
18. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of hepatitis E virus infection in sporadic acute hepatitis].
Jiang Y; Bi S; Li J; Lu J; Liao S; Zhao H; Wang P; Zhan M; Liu C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):177-80. PubMed ID: 15619831
[TBL] [Abstract][Full Text] [Related]
20. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
